Abstract

The synthesis of silver nanoparticles (AgNPs) by microorganisms recently gained a greater interest due to its potential to produce them in various sizes and morphologies. In this study, for AgNP biosynthesis, we used a new Pseudomonas strain isolated from a consortium associated with the Antarctic marine ciliate Euplotes focardii. After incubation of Pseudomonas cultures with 1 mM of AgNO3 at 22 °C, we obtained AgNPs within 24 h. Scanning electron (SEM) and transmission electron microscopy (TEM) revealed spherical polydispersed AgNPs in the size range of 20–70 nm. The average size was approximately 50 nm. Energy dispersive X-ray spectroscopy (EDS) showed the presence of a high intensity absorption peak at 3 keV, a distinctive property of nanocrystalline silver products. Fourier transform infrared (FTIR) spectroscopy found the presence of a high amount of AgNP-stabilizing proteins and other secondary metabolites. X-ray diffraction (XRD) revealed a face-centred cubic (fcc) diffraction spectrum with a crystalline nature. A comparative study between the chemically synthesized and Pseudomonas AgNPs revealed a higher antibacterial activity of the latter against common nosocomial pathogen microorganisms, including Escherichia coli, Staphylococcus aureus and Candida albicans. This study reports an efficient, rapid synthesis of stable AgNPs by a new Pseudomonas strain with high antimicrobial activity.

Highlights

  • Nanotechnology has become an emerging field in the area of biotechnology, dealing with the synthesis, design and manipulation of particles with approximate sizes from 1 to 100 nm

  • The aim of this study is to develop a simple and low-cost approach for AgNP intracellular synthesis using a new Pseudomonas strain isolated from a consortium associated with the psychrophilic marine ciliated protozoon Euplotes focardii [20], which we named Pseudomonas sp. ef1 [21]

  • We showed that the AgNPs produced by Pseudomonas sp. ef1 possess higher antimicrobial activity with respect to those chemically synthesized, which could be used against common pathogenic microorganisms

Read more

Summary

Introduction

Nanotechnology has become an emerging field in the area of biotechnology, dealing with the synthesis, design and manipulation of particles with approximate sizes from 1 to 100 nm. AgNP synthesis, including microwave, biochemical and electrochemical synthesis, chemical reduction (aqueous and non-aqueous), irradiation, ultrasonic-associated, photo-induced, photo-catalytic and microemulsion methods. These methodologies have various disadvantages because they imply high energy consumption and the use of toxic reagents with the generation of hazardous waste, which causes potential risks to the environment and human health [2,3]. In these days, there is a growing need to develop simple, cost-effective, reliable, bio-compatible and eco-friendly approaches.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call